AFS
KIN

Amtrust Financial Services’s Kindred Biosciences, Inc. KIN Stock Holding History

Amtrust Financial Services’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-33,531
Closed -$367K – 53
2018
Q4 		$367K Sell
33,531
-96,523
-74% -$1.22M 0.49% 28
2018
Q3 		$1.81M Sell
130,054
-77,541
-37% -$1.05M 1.34% 18
2018
Q2 		$2.21M Buy
207,595
+105,274
+103% +$1.03M 1.57% 15
2018
Q1 		$885K Sell
102,321
-70,779
-41% -$621K 0.57% 34
2017
Q4 		$1.64M Sell
173,100
-76,000
-31% -$594K 0.75% 35
2017
Q3 		$1.96M Sell
249,100
-900
-0.4% -$6.75K 1.04% 30
2017
Q2 		$2.15M Hold
250,000
– – 1.19% 24
2017
Q1 		$1.76M Buy
+250,000
New +$1.57M 0.36% 28

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Amtrust Financial Services's KIN Position: Q1 2019 in Review

Amtrust Financial Services sold out of Kindred Biosciences, Inc. (KIN) in Q1 2019, closing a stake of 33,531 shares — an estimated $367K sold.

Amtrust Financial Services first reported a position in KIN in Q1 2017 and held it in 8 quarters. The position peaked at $2.21M in Q2 2018. 75 funds tracked by Wall St. Rank hold KIN as of Q1 2019.

  • Amtrust Financial Services reported no remaining Kindred Biosciences, Inc. position as of Q1 2019 after selling out during the quarter.
  • Amtrust Financial Services sold 33,531 Kindred Biosciences, Inc. shares in Q1 2019, an estimated $367K.
  • Amtrust Financial Services first reported a position in Kindred Biosciences, Inc. in Q1 2017 and held it in 8 quarters.
  • Amtrust Financial Services's Kindred Biosciences, Inc. position peaked at $2.21M in Q2 2018.
  • 75 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2019.

Based on Amtrust Financial Services's 13F filing for Q1 2019, filed 14 May 2019.